Expert Eye Care at One of China's Premier Academic Medical Centers
The Department of Ophthalmology at Huashan Hospital — affiliated with Fudan University — is one of China's most distinguished ophthalmology centers, with a particular national reputation for excellence in neuro-ophthalmology, retinal disease, glaucoma, corneal disease, and ocular oncology. The department's unique strength in neuro-ophthalmology — reflecting its close integration with Huashan's world-renowned neurology and neurosurgery departments — makes it the premier destination in China for patients with visual symptoms arising from neurological conditions, pituitary tumors, intracranial hypertension, and other neuro-ophthalmic disorders.
For international patients seeking expert ophthalmology care in Shanghai — whether for a complex retinal condition, glaucoma, neuro-ophthalmic visual loss, corneal disease, or a rare ocular condition — Huashan Hospital's ophthalmology department offers a level of expertise and multidisciplinary integration that is among the finest in China. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their care journey.
About the Department
Huashan Hospital's ophthalmology department is a national key clinical specialty operating a comprehensive eye unit with dedicated inpatient wards, a full-service outpatient eye clinic, a neuro-ophthalmology clinic, a retina and vitreous service, a glaucoma clinic, a cornea and external disease service, an ocular oncology clinic, a low vision rehabilitation service, and a state-of-the-art ophthalmic imaging center.
The department's ophthalmic imaging center provides the full range of modern diagnostic imaging including optical coherence tomography (OCT), OCT angiography (OCTA), fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), visual field testing, electroretinography (ERG), visual evoked potentials (VEP), and orbital MRI — enabling precise diagnosis of complex retinal, optic nerve, and neuro-ophthalmic conditions. Faculty members publish regularly in leading ophthalmology journals including Ophthalmology, JAMA Ophthalmology, British Journal of Ophthalmology, and Investigative Ophthalmology & Visual Science.
Conditions Treated
Neuro-Ophthalmology
- Optic Neuritis — MS-associated, NMOSD-associated (AQP4-IgG), and MOGAD optic neuritis; high-dose corticosteroids; disease-modifying therapy coordination with neurology
- Ischemic Optic Neuropathy — Arteritic (GCA) and non-arteritic AION; urgent corticosteroid therapy for GCA; vascular risk factor management
- Compressive Optic Neuropathy — Visual field monitoring for pituitary adenomas and other sellar/parasellar tumors; surgical decompression coordination with neurosurgery
- Papilledema & Idiopathic Intracranial Hypertension — Visual field monitoring; acetazolamide therapy; CSF diversion coordination with neurosurgery
- Diplopia & Ocular Motility Disorders — Third, fourth, and sixth nerve palsies; internuclear ophthalmoplegia; skew deviation; prism therapy and strabismus surgery
- Nystagmus — Acquired nystagmus evaluation; neurological cause identification; gabapentin and memantine therapy
- Visual Field Defects — Hemianopia and quadrantanopia from stroke, tumor, and other neurological causes; neurorehabilitation coordination
- Horner Syndrome — Pharmacological testing and imaging for underlying cause
- Myasthenia Gravis (Ocular) — Ptosis and diplopia management; coordination with neurology for systemic MG
- Thyroid Eye Disease (Graves' Ophthalmopathy) — Teprotumumab for active moderate-to-severe TED; orbital decompression; strabismus surgery; eyelid surgery
Retinal Disease
- Age-Related Macular Degeneration (AMD) — Anti-VEGF therapy (ranibizumab, aflibercept, bevacizumab, faricimab); photodynamic therapy for polypoidal choroidal vasculopathy
- Diabetic Retinopathy & Diabetic Macular Edema — Anti-VEGF injections; laser photocoagulation; vitrectomy for tractional retinal detachment
- Retinal Vein Occlusion — Anti-VEGF and corticosteroid implants for macular edema
- Retinal Detachment — Pneumatic retinopexy, scleral buckle, and pars plana vitrectomy
- Macular Hole — Pars plana vitrectomy with ILM peeling and gas tamponade
- Epiretinal Membrane — Vitrectomy and membrane peeling
- Choroidal Neovascularization — Anti-VEGF therapy for myopic CNV and other causes
- Inherited Retinal Dystrophies — Genetic testing; voretigene neparvovec (Luxturna) for RPE65-associated retinal dystrophy; clinical trial access for emerging gene therapies
- Uveitis — Anterior, intermediate, posterior, and panuveitis; infectious and non-infectious causes; corticosteroids, immunosuppression, and biologic therapy
Glaucoma
- Primary Open-Angle Glaucoma — Medical management (prostaglandin analogues, beta-blockers, CAIs, alpha-agonists, Rho kinase inhibitors); laser trabeculoplasty (SLT); trabeculectomy and tube shunt surgery
- Normal-Tension Glaucoma — IOP-lowering therapy; vascular risk factor management
- Angle-Closure Glaucoma — Laser peripheral iridotomy; phacoemulsification for lens-induced angle closure; goniosynechialysis
- Secondary Glaucomas — Neovascular, uveitic, pseudoexfoliative, and pigmentary glaucoma
- Minimally Invasive Glaucoma Surgery (MIGS) — iStent, Hydrus microstent, and other MIGS devices combined with cataract surgery
Cornea & External Disease
- Keratoconus — Corneal cross-linking (CXL); rigid gas-permeable and scleral contact lenses; deep anterior lamellar keratoplasty (DALK)
- Corneal Transplantation — Penetrating keratoplasty (PK), DALK, DSAEK, and DMEK for various corneal conditions
- Dry Eye Disease — Artificial tears, cyclosporine (Restasis), lifitegrast (Xiidra), and intense pulsed light (IPL) therapy; meibomian gland dysfunction management
- Infectious Keratitis — Bacterial, fungal, acanthamoeba, and herpes simplex keratitis
- Bullous Keratopathy — DSAEK and DMEK for endothelial failure
Ocular Oncology
- Uveal Melanoma — Plaque brachytherapy; proton beam therapy coordination; enucleation; genetic prognostication (GEP, FISH)
- Retinoblastoma — Intra-arterial chemotherapy; intravitreal chemotherapy; systemic chemotherapy; laser and cryotherapy; enucleation
- Conjunctival & Eyelid Tumors — Surgical excision; mitomycin C for conjunctival intraepithelial neoplasia
- Orbital Tumors — Orbital lymphoma, cavernous hemangioma, and other orbital masses; surgical and radiation management
Cataract & Refractive Surgery
- Cataract Surgery — Phacoemulsification with premium IOL implantation (toric, multifocal, extended depth of focus); femtosecond laser-assisted cataract surgery
- Refractive Surgery — LASIK, SMILE, and PRK for myopia and astigmatism correction; phakic IOL implantation (ICL) for high myopia
Neuro-Ophthalmology: A Unique Strength
Huashan Hospital's neuro-ophthalmology program is one of the most distinguished in China, reflecting the department's unique integration with Huashan's world-class neurology and neurosurgery programs. This integration creates an unparalleled environment for patients with visual symptoms arising from neurological conditions:
- Seamless collaboration with neurology for MS, NMOSD, MOGAD, and other neuro-inflammatory conditions causing optic neuritis
- Close coordination with neurosurgery for visual field monitoring and surgical timing in pituitary adenomas and other compressive lesions
- Integrated management of papilledema and idiopathic intracranial hypertension with neurology and neurosurgery
- Expert evaluation of diplopia and ocular motility disorders with neurological cause identification
- Thyroid eye disease management with endocrinology for Graves' disease
Why International Patients Choose Huashan Ophthalmology
- Neuro-Ophthalmology Excellence — China's premier neuro-ophthalmology program, uniquely integrated with the country's top neurology and neurosurgery departments
- Thyroid Eye Disease Expertise — Teprotumumab and multidisciplinary management with endocrinology for Graves' ophthalmopathy
- Retinal Disease Program — Comprehensive anti-VEGF therapy and vitreoretinal surgery for AMD, diabetic retinopathy, and retinal detachment
- Inherited Retinal Dystrophy — Genetic testing and access to gene therapy (Luxturna) for RPE65-associated disease
- Ocular Oncology — Uveal melanoma and retinoblastoma management with genetic prognostication
- Cost-Effectiveness — World-class eye care at significantly lower cost than equivalent treatment in Western countries
The CMCS Patient Journey
- Initial Inquiry — Share your eye disease history, visual acuity, visual field results, OCT reports, and current medications with CMCS.
- Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
- Specialist Matching — We identify the most appropriate ophthalmologist based on your condition — neuro-ophthalmology, retina, glaucoma, cornea, or ocular oncology.
- Priority Scheduling — We secure a consultation with minimal waiting time.
- Travel & Logistics — Assistance with visa invitation letters, accommodation near Huashan Hospital, and Shanghai airport transfers.
- On-Site Concierge — Bilingual coordinators accompany you throughout your hospital visits, managing registration, translation, and communication.
- Diagnostic Support — Full coordination of OCT, visual field testing, FFA, ERG, VEP, and other required investigations.
- Post-Treatment Follow-Up — Test result translation, treatment plan interpretation, and remote follow-up coordination after you return home.
Book a Consultation
If you are seeking expert ophthalmology care in Shanghai — whether for neuro-ophthalmic visual loss, retinal disease, glaucoma, corneal disease, thyroid eye disease, or ocular cancer — CMCS can arrange a specialist consultation with Huashan Hospital's ophthalmology team.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 commenti